http://www.fatetherapeutics.com
Fate Therapeutics, Inc. Company Intro
for immuno-oncology [CD34+] for immuno-regulation [T-Cell, NK Cell]
Industry
Healthcare
Fate Therapeutics, Inc. Headquaters
3535 General Atomics Court
San Diego,92121
United States
Fate Therapeutics, Inc. Share price
14 Sep 2022 09:12 GMT
$27.64
-1.48 (-5.08 %)
Fate Therapeutics, Inc. Market cap
$2.444 B
WMC RANKING
2023
Fate Therapeutics, Inc. # 146
BiotechnologyLatest Fate Therapeutics, Inc. News
29 Mar 2023
CD276 Antibody Clinical Trials & Market Sales Forecasts ...
Current leaders in the CD276 targeted checkpoint inhibitors include; Daiichi Sankyo, YmAb Therapeutics, AbbVie, BioAtla, Fate Therapeutics, MacroGenics, and...
29 Mar 2023
Fate Therapeutics Inc. (FATE) Stock: Navigating the Market ...
The average trading volume for FATE on March 29, 2023 was 4.09M shares. FATE) stock's latest price update. Fate Therapeutics Inc. (NASDAQ: FATE)'s stock price...
29 Mar 2023
Selvita's growth continues with completion of new Krakow HQ
Rowe Price Associates, Inc., UPMC Enterprises, and Ring's existing institutional shareholders. Ring Therapeutics has been busy publishing a record of pre-...
WMC Market Score
WMC Market to Revenue Score
Fate Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Fate Therapeutics, Inc. | USD | $40,061 | $179,864 | $-184,956 | $24,440B | 146 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Fate Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Fate Therapeutics, Inc. Post vs Top 4 Industry Competitors
Fate Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Fate Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Fate Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Fate Therapeutics, Inc. | 0.44 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
